CD30 expression is strongly associated with SM: more than 80% of patients with smoldering/aggressive SM or MC leukemia frequently show high CD30 surface expression, and also patients with ISM and tryptase levels ≥50 ng/mL have frequently positive and highly positive CD30 expression [87]. The gene discussed is TNFRSF8; the disease is systemic mastocytosis.